Dr. Christy Sandborg, MD

Publications

• A167: variations in patterns of care across pediatric rheumatic diseases in the childhood arthritis, 2014

• Secondary alysis of APPLE study suggests atorvastatin may reduce atherosclerosis progression, 2014

• Shrinking Lung Syndrome as a Manifestation of Pleuritis, 2013

• An i2b2-based, generalizable, open source, self-scaling chronic disease registry, 2013

• A New Era in the Treatment of Systemic Juvenile Idiopathic Arthritis, 2012

• Correlation alyses of clinical and molecular findings identify candidate biological pathways, 2012

• Algorithm development for corticosteroid magement, 2012

• European ancestry decreases the risk of early onset, severe lupus nephritis in a single center, 2012

• Use of atorvastatin in systemic lupus erythematosus in children and adolescents, 2012

• The Childhood Arthritis & Rheumatology Research Alliance Network Registry, 2011

• Implementing an Interoperable Persol Health Record in Pediatrics, 2011

• Plasma profiles in active systemic juvenile idiopathic arthritis, 2010

• Behcet's disease and heart transplantation: A word of caution, 2010

• Living Profiles: Design of a health media platform for teens with special healthcare needs, 2010

• Laboratory markers of cardiovascular risk in pediatric SLE: the APPLE baseline cohort, 2010

• Decrease in Hospital, 2010

• PEDIATRIC RHEUMATIC DISEASE Standards of care for JIA-the basic foundation for quality, 2010

• Distribution of circulating cells, 2010

• Premature Atherosclerosis in Pediatric Systemic Lupus Erythematosus, 2009

• Consensus development of a corticosteroid, 2008

• Clinical laboratory markers of cardiovascular risk in a pediatric SLE cohort, 2008

• Adalimumab with or without methotrexate in juvenile rheumatoid arthritis, 2008

• Therapy Insight: cardiovascular disease in pediatric systemic lupus erythematosus, 2008

• Reduced levels of FasL and apoptosis resistance in SJIA monocytes, 2008

• Predictors of increased carotid intima media thickness, 2007

• Distinct molecular and cellular aspects of systemic juvenile idiopathic arthritis, 2007

• Magement of dyslipidemia in children and adolescents with systemic lupus erythematosus, 2007

• Availability of pediatric rheumatology training in United States pediatric residencies., 2006

• Rafting the ethical rapids., 2006

• Candidate early predictors for progression to joint damage in systemic juvenile idiopathic, 2006

• Systemic hyalinosis: A distinctive early childhood, 2006

• Neuropsychiatric manifestations in pediatric systemic lupus erythematosus, 2006

• Summary of the 2005 annual research and education meeting of the Spondyloarthritis Research

• The future of rheumatology research: the Childhood Arthritis and Rheumatology Research Alliance., 2006

• Differential expression of immune parameters in systemic juvenile idiopathic arthritis, 2006

• History of infection before the onset of juvenile dermatomyositis, 2005

• The first step: DR outside the hospital and the role of pediatric medical care providers, 2005

• Dyslipoproteinemia and premature atherosclerosis in pediatric systemic lupus erythematosus., 2004

• Adolescent rheumatology transitiol care: steps to bringing health policy into practice, 2004

• Frontal lobe seizures and uveitis associated with acute human parvovirus B19 infection, 2004

• Role of pediatric and internist rheumatologists in treating children with rheumatic diseases, 2004

• Access to pediatric rheumatology care in the United States, 2003

• Novel therapies in pediatric rheumatic diseases, 2003

• Growth delay in systemic JRA: Interplay between steroid usage and disease severity, 2002

• Magnetic resonce imaging in the diagnosis and follow up of Takayasu's arteritis in children, 2002

• Expression of autoimmunity in the transition from childhood to adulthood, 2002

• Type 1 diabetes mellitus, 2002

• Systemic lupus erythematosus and antiphospholipid syndrome in children and adolescents, 2001

• Development of systemic lupus erythematosus following autologous bone marrow transplant, 2001

• A randomized trial of methotrexate in newly diagnosed patients with type 1 diabetes mellitus, 2000

• Position statement of the American college of rheumatology regarding referral of children, 1999

• Progressive multifocal leukoencephalopathy in a 15-year-old boy with scleroderma, 1998

• Childhood systemic lupus erythematosus and neotal lupus syndrome., 1998

• Decreased IL-4 production in new onset type I insulin-dependent diabetes mellitus, 1996

• IL-4 EXPRESSION IN HUMAN T-CELLS IS SELECTIVELY INHIBITED BY IL-1-ALPHA AND IL-1-BETA, 1995

• HIV TYPE-1 INDUCTION OF INTERLEUKIN-1 AND INTERLEUKIN-6 PRODUCTION BY HUMAN THYMIC CELLS, 1994

• HIV-1 INFECTION OF MACROPHAGES PROMOTES LONG-TERM SURVIVAL AND SUSTAINED-RELEASE OF, 1994

• A TURALLY-OCCURRING 6-9-KILODALTON INTERLEUKIN-1, 1991

• INTERLEUKIN-1 AND A 7-KDA T-CELL INHIBITORY MONOKINE REFLECT DISEASE-ACTIVITY IN INFECTION WITH, 1990

• MODULATION OF IL-1-ALPHA, IL-1-BETA, 1989

• CHANGES IN CIRCULATING MONOCYTES IN PATIENTS WITH PROGRESSIVE SYSTEMIC-SCLEROSIS, 1987

• INTERLEUKIN-1 INHIBITOR MASKS HIGH INTERLEUKIN-1 PRODUCTION IN ACQUIRED-IMMUNODEFICIENCY-SYNDROME, 1987

• INCREASED PRODUCTION OF AN INTERLEUKIN-1, 1986

• SKIN, JOINT, AND PULMORY CHANGES IN TYPE-I DIABETES-MELLITUS, 1986

• LOSS OF EPIDERMAL LANGERHANS CELLS AND ENDOTHELIAL-CELL HLA, 1986

• STUDIES OF AN INTERLEUKIN-1 INHIBITOR - CHARACTERIZATION AND CLINICAL-SIGNIFICANCE, 1986

• INTERLEUKIN-1 PRODUCTION BY MONONUCLEAR-CELLS FROM PATIENTS WITH SCLERODERMA, 1985

• SCLERODERMA-LIKE CHANGES IN INSULIN-DEPENDENT DIABETES-MELLITUS - CLINICAL AND BIOCHEMICAL-STUDIES, 1984

• NEOTAL HYPER-TREMIA ASSOCIATED WITH ELEVATED SODIUM CONCENTRATION OF BREAST-MILK, 1980

• COMPETITION FOR HOST ESSENTIAL AND NONESSENTIAL FATTY-ACIDS BY EHRLICH ASCITES-CARCINOMA IN MICE, 1977

• BLOOD-SAMPLING TECHNIQUES FOR STUDYING RAPIDLY TURNING OVER METABOLIC FUELS IN MICE, 1976